Dabur India anticipates modest revenue growth for the first quarter of fiscal year 2026. Unseasonal rains impacted the beverages segment. Home and Personal Care division shows strength, especially in urban markets. Dabur Honitus leads healthcare growth. International business delivers double-digit growth. Nuvama maintains a ‘Buy’ rating with a target price of Rs 615.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets